U.S.-based telehealth firm Hims & Hers is preparing to launch replica versions of popular obesity medications in the UK and Europe, signaling an aggressive expansion into the global weight-loss market. The company says the move is part of a broader strategy to offer more affordable and accessible treatment options through its digital healthcare platform.
LONDON DAILY ARCHIVE
Hims & Hers Plans UK and EU Launch of Replica Obesity Drugs
Digital health company aims to expand weight loss offerings
04 June 2025 · 04:40 UTC